SEARCH

SEARCH BY CITATION

References

  • Amandi-Burgermeister E., Tibes U., Kaiser B. M., Friebe W. G. and Scheuer W. V. (1997) Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2. Eur. J. Pharmacol. 326, 237250.
  • Arbibe L., Vial D., Rosinski-Chupin I., Havet N., Huerre M., Vargaftig B. B. and Touqui L. (1997) Endotoxin induces expression of type␣II␣phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-α in lipopolysaccharide- induced type II phospholipase A2 synthesis. J. Immunol. 159, 391400.
  • Balsinde J., Balboa M. A. and Dennis E. A. (1998) Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2. Proc. Natl Acad. Sci. USA 95, 79517956.
  • Balsinde J. and Dennis E. A. (1996) Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J. Biol. Chem. 271, 67586765.
  • Balsinde J. and Dennis E. A. (1997) Function and inhibition of intracellular calcium-independent phospholipase A2. J. Biol. Chem. 272, 1606916072.
  • Beasley D. (1999) COX-2 and cytosolic PLA2 mediate IL-1β-induced cAMP production in human vascular smooth muscle cells. Am. J.␣Physiol. 276, H1369H1378.
  • Bianchi M., Dib B. and Panerai A. E. (1998) Interleukin-1 and nociception in the rat. J. Neurosci. Res. 53, 645650.
  • Bonventre J. V., Huang Z., Taheri M. R., O'Leary E., Li E., Moskowitz M. A. and Sapirstein A. (1997) Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390, 622625.
  • Chen M., Yang Z.-D., Naji A. and Wolf B. A. (1996) Identification of calcium-dependent phospholipase A2 isoforms in human and rat pancreatic islets and insulin secreting β-cell lines. Endocrinology 137, 29012909.
  • Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform␣extraction. Anal. Biochem. 162, 156159.DOI: 10.1006/abio.1987.9999
  • Dennis E. A. (1994) Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269, 1305713060.
  • Dennis E. A. (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22, 12.
  • Edstrom A., Briggman M. and Ekstrom P. A. R. (1996) Phospholipase A2 activity is required for outgrowth of sensory axons in cultured adult sciatic nerves. J. Neurosci. Res. 43, 183189.DOI: 10.1002/(SICI)1097-4547(19960115)43:2<183::AID-JNR6>3.0.CO;2-C
  • Ferreira S. H., Lorenzetti B. B., Bristow A. F. and Poole S. (1988) Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334, 698700.
  • Fukuoka H., Kawatani M., Hisamitsu T. and Takeshige C. (1994) Cutaneous hyperalgesia induced by peripheral injection of interleukin-1β in the rat. Brain Res. 657, 133140.
  • Garcia-Pastor P., Randazzo A., Gomez-Paloma L., Alcaraz M. J. and Paya M. (1999) Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation. J.␣Pharmacol. Exp. Ther. 289, 166172.
  • Glover S., Bayburt T., Jonas M., Chi E. and Gelb M. H. (1995) Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelop in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J. Biol. Chem. 270, 1535915367.
  • Hay C. H., Trevethick M. A., Wheeldon A., Bowers J. S. and De Belleroche J. S. (1997) The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience 78, 843850.
  • Hingtgen C. M., Waite K. J. and Vasko M. R. (1995) Prostaglandins facilitate peptide release from rat sensory neurons by activating the␣adenosine 3′,5′-cyclic-monophosphate transduction cascade. J.␣Neurosci. 15, 54115419.
  • Hirota N., Kuraishi Y., Hino Y., Sato Y., Satoh M. and Takagi H. (1985) Met-enkephalin and morphine but not dynorphin inhibit noxious stimuli-induced release of substance P from rabbit dorsal horn in situ. Neuropharmacology 24, 567570.
  • Hornfelt M., Ekstrom P. A. R. and Edstrom A. (1999) Involvement of axonal phospholipase A2 activity in the outgrowth of adult mouse sensory axons in vitro. Neuroscience 91, 15391547.DOI: 10.1016/S0306-4522(98)00684-8
  • Inoue A., Hashimoto T., Hide I., Nishio H. and Nakata Y. (1997) 5-hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J.␣Neurochem. 68, 128133.
  • Inoue A., Ikoma K., Morioka N., Kumagai K., Hashimoto T., Hide I. and Nakata Y. (1999) Interleukin-1β induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J.␣Neurochem. 73, 22062213.
  • Inoue A., Seto M., Sugita S., Hide I., Hirose T., Koga N., Kikuchi T. and Nakata Y. (1998) Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Mol. Brain Res. 55, 285292.
  • Kamisaki Y., Nakamoto K., Wada K. and Itoh T. (1995) Nitric oxide regulates substance P release from rat spinal cord synaptosomes. J.␣Neurochem. 65, 20502056.
  • Kramer R. M., Hession C., Johansen B., Hayes G., McGray P., Chow E. P., Tizard R. and Pepinsky R. B. (1989) Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264, 57685775.
  • Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S. and Hershey A. D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl Acad. Sci. USA 84, 881885.
  • Kuwata H., Nakatani Y., Murakami M. and Kudo I. (1998) Cytosolic␣phospholipase A2 is required for cytokine-induced expression␣of␣type IIA secretory phospholipase A2 that mediates␣optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273, 17331740.
  • Lembeck F. and Holzer P. (1979) Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch. Pharmacol. 310, 175183.
  • Lin L. L., Lin A. Y. and DeWitt D. L. (1992) Interleukin-1α induces the␣accumulation of cytosolic phospholipase A2 and the release␣of prostaglandin E2 in human fibroblasts. J. Biol. Chem. 267, 2345123454.
  • Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A. and Davis R. J. (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269278.
  • Liu H., Mantyh P. W. and Basbaum A. I. (1997) NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386, 721724.
  • Ma Z., Ramanadham S., Hu Z. and Turk J. (1998) Cloning and expression of a group IV cytosolic Ca2+-dependent phospholipase␣A2 from rat pancreatic islets. Comparison of the expressed␣activity with that of an islet group II cytosolic Ca2+-independent phospholipase A2. Biochim. Biophys. Acta 1391, 384400.
  • Magolda R. L., Ripka W. C., Galbraith W., Johnson P. R. and Rudnick M. S. (1985) Novel synthesis of potent site-specific phospholipase A2 inhibitors. Prostaglandins, Leukotrienes and Lipoxins, pp. 669–676. Plenum, New York.
  • Malcangio M., Bowery N. G., Flower R. J. and Perretti M. (1996) Effect of Interleukin-1β on the release of substance P from rat isolated spinal cord. Eur. J. Pharmacol. 299, 113118.
  • Miyake A., Yamamoto H., Kubota E., Hamaguchi K., Kouda A., Honda K. and Kawashima H. (1993) Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2. Br. J. Pharmacol. 110, 447453.
  • Murakami M., Matsumoto R., Urade Y., Austen K. F. and Arm J. P. (1995) c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE- dependent prostaglandin D2 generation in immature mouse mast cells. J. Biol. Chem. 270, 32393246.
  • Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., Ichikawa A., Aze Y., Tanaka T., Yoshida N., Ueno A., Oh-ishi S. and Narumiya S. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388, 678682.
  • Nakano T., Ohara O., Teraoka H. and Arita H. (1990) Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 261, 171174.
  • Oka S. and Arita H. (1991) Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem. 266, 99569960.
  • Paul J. A. and Gregson N. A. (1992) An immunohistochemical study of phospholipase A2 in peripheral nerve during Wallerian degeneration. J. Neuroimmun. 39, 3147.
  • Quik M. (1987) Characterization and localization of phospholipase A2 activity in sympathetic ganglia. J. Neurochem. 48, 217224.
  • Randic M. and Miletic V. (1977) Effect of substance P in cat dorsal horn neurons activated by noxious stimuli. Brain Res. 128, 164169.
  • Rao G. N., Glasgow W. C., Eling T. E. and Runge M. S. (1996) Role of␣hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein (AP-1) activity. J. Biol. Chem. 271, 2776027764.
  • Riendeau D., Guay J., Weech P. K., Laliberte F., Yergey J., Li C., Desmarais S., Perrier H., Liu S., Nicoll-Griffith D. and Street I. P. (1994) Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 269, 1561915624.
  • Safieh-Garabedian B., Kanaan S. A., Haddad J. J., Jaoude P. A., Jabbur S. J. and Saade N. E. (1997) Involvement of interleukin-1β, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia. Br. J. Pharmacol. 121, 16191626.
  • Saria A. (1984) Substance P in sensory nerve fibers contributes to the development of oedema in the rat hind paw after thermal injury. Br.␣J. Pharmacol. 82, 217222.
  • Schalkwijk C. G., Vervoordeldonk M., Pfeilschifter J. and Van Den Bosch H. (1993) Interleukin-1β-induced cytosolic phospholipase A2 activity and protein synthesis is blocked by dexemethasone in rat mesangial cells. FEBS Lett. 333, 339343.
  • Street I. P., Lin H.-K., Laliberte F., Ghomashchi F., Wang Z., Perrier H., Tremblay N. M., Huang Z., Weech P. K. and Gelb M. H. (1993) Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 32, 59355940.
  • Uozumi N., Kume K., Nagase T., Nakatani N., Ishii S., Tashiro F., Komagata Y., Maki K., Ikuta K., Ouchi Y., Miyazaki J. and Shimizu T. (1997) Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390, 618622.
  • Vervoordeldonk M. J. B. M., Torra I. M. P., Aarsman A. J. and Van Den Bosch H. (1996) Aspirin inhibits expression of the interleukin-1β-inducible group II phospholipase A2. FEBS Lett. 397, 108112.
  • Walsh D. T., Weg V. B., Williams T. J. and Nourshargh S. (1995) Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK 1 receptor antagonists and the role of endogenous mediators. Br. J. Pharmacol. 114, 13431350.
  • Watkins L. R., Wiertelak E. P., Goehler L. E., Smith K. P., Martin D. and Maier S. F. (1994) Characterization of cytokine-induced hyperalgesia. Brain Res. 654, 1526.
  • Wu T., Levine S. J., Cowan M., Logun C., Angus C. W. and Shelhamer J. H. (1997) Antisense inhibition of 85-kDa cPLA2 blocks␣arachidonic acid release from airway epithelial cells. Am. J.␣Physiol. 273, L331L338.